The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (15.94) USD. With the latest stock price at 7.31 USD, the upside of Neogenomics Inc based on DCF is -318.1%.
Based on the latest price of 7.31 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 318.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.1% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (59.38) - (10.21) | (15.94) |
| Upside | -912.3% - -239.6% | -318.1% |